Artelo Biosciences to Participate in BIO Digital and The Investor Summit Conferences

LA JOLLA, Calif., June 03, 2020 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system and related pathways, announced today that it will be participating in two upcoming virtual conferences.